Matches in SemOpenAlex for { <https://semopenalex.org/work/W3112666175> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W3112666175 endingPage "iii420" @default.
- W3112666175 startingPage "iii420" @default.
- W3112666175 abstract "Abstract OBJECTIVE Refractory symptomatic plexiform neurofibromas (PNF) and inoperable refractory low grade gliomas (LGG) pose a clinical challenge that may be life threatening. Phase 1 and 2 clinical trials of MEK inhibition with selumetinib in inoperable PNF and LGG have demonstrated promising results in pediatrics, however access has been limited to enrollment on clinical trial. Phase 1 clinical trial for trametinib a MEK 1 and 2 inhibitor has been completed, publication is pending. Thus we have treated a series of children on a compassionate basis with extensive PN or LGG refractory disease with trametinib, as this is available in Canada. METHODS We have treated children with trametinib on a compassionate basis in our province since 2017. Review of the clinical data regarding this therapy has been IRB approved. RESULTS Two young patients were treated for indication of life threatening extensive PNF and have had tumor shrinkage and improvement of clinical status. Treatment has been complicated by paronychiae, eczema exacerbation, chondrodermatitis nodularis helicis, RSV and influenza B infection and CTCAE grade 2 pneumonia. In spite of the side effects these two patients remain on treatment due to clear benefit from therapy including: improved respiratory compromise, hearing and dysphagia. We will present the data of additional patients treated with trametinib. CONCLUSION Trametinib is an effective therapy for life threatening PNF by changing the natural history of tumor growth in young children. Further data is required in terms of tolerance, efficacy and durability of response in such patients in the setting of clinical trials." @default.
- W3112666175 created "2020-12-21" @default.
- W3112666175 creator A5007430650 @default.
- W3112666175 creator A5007750236 @default.
- W3112666175 creator A5012123537 @default.
- W3112666175 creator A5012407631 @default.
- W3112666175 creator A5018867808 @default.
- W3112666175 creator A5030028593 @default.
- W3112666175 creator A5035559847 @default.
- W3112666175 creator A5039296361 @default.
- W3112666175 creator A5039848715 @default.
- W3112666175 creator A5059000453 @default.
- W3112666175 creator A5063329485 @default.
- W3112666175 creator A5066213759 @default.
- W3112666175 creator A5072130548 @default.
- W3112666175 creator A5075134742 @default.
- W3112666175 creator A5085214921 @default.
- W3112666175 date "2020-12-01" @default.
- W3112666175 modified "2023-09-23" @default.
- W3112666175 title "NFB-12. TRAMETINIB THERAPY FOR PEDIATRIC PATIENTS WITH REFRACTORY LOW GRADE GLIOMA OR EXTENSIVE SYMPTOMATIC PLEXIFORM NEUROFIBROMA" @default.
- W3112666175 doi "https://doi.org/10.1093/neuonc/noaa222.615" @default.
- W3112666175 hasPublicationYear "2020" @default.
- W3112666175 type Work @default.
- W3112666175 sameAs 3112666175 @default.
- W3112666175 citedByCount "0" @default.
- W3112666175 crossrefType "journal-article" @default.
- W3112666175 hasAuthorship W3112666175A5007430650 @default.
- W3112666175 hasAuthorship W3112666175A5007750236 @default.
- W3112666175 hasAuthorship W3112666175A5012123537 @default.
- W3112666175 hasAuthorship W3112666175A5012407631 @default.
- W3112666175 hasAuthorship W3112666175A5018867808 @default.
- W3112666175 hasAuthorship W3112666175A5030028593 @default.
- W3112666175 hasAuthorship W3112666175A5035559847 @default.
- W3112666175 hasAuthorship W3112666175A5039296361 @default.
- W3112666175 hasAuthorship W3112666175A5039848715 @default.
- W3112666175 hasAuthorship W3112666175A5059000453 @default.
- W3112666175 hasAuthorship W3112666175A5063329485 @default.
- W3112666175 hasAuthorship W3112666175A5066213759 @default.
- W3112666175 hasAuthorship W3112666175A5072130548 @default.
- W3112666175 hasAuthorship W3112666175A5075134742 @default.
- W3112666175 hasAuthorship W3112666175A5085214921 @default.
- W3112666175 hasBestOaLocation W31126661751 @default.
- W3112666175 hasConcept C121332964 @default.
- W3112666175 hasConcept C126322002 @default.
- W3112666175 hasConcept C142424586 @default.
- W3112666175 hasConcept C143998085 @default.
- W3112666175 hasConcept C184235292 @default.
- W3112666175 hasConcept C2778472372 @default.
- W3112666175 hasConcept C535046627 @default.
- W3112666175 hasConcept C57074206 @default.
- W3112666175 hasConcept C71924100 @default.
- W3112666175 hasConcept C86803240 @default.
- W3112666175 hasConcept C87355193 @default.
- W3112666175 hasConcept C95444343 @default.
- W3112666175 hasConceptScore W3112666175C121332964 @default.
- W3112666175 hasConceptScore W3112666175C126322002 @default.
- W3112666175 hasConceptScore W3112666175C142424586 @default.
- W3112666175 hasConceptScore W3112666175C143998085 @default.
- W3112666175 hasConceptScore W3112666175C184235292 @default.
- W3112666175 hasConceptScore W3112666175C2778472372 @default.
- W3112666175 hasConceptScore W3112666175C535046627 @default.
- W3112666175 hasConceptScore W3112666175C57074206 @default.
- W3112666175 hasConceptScore W3112666175C71924100 @default.
- W3112666175 hasConceptScore W3112666175C86803240 @default.
- W3112666175 hasConceptScore W3112666175C87355193 @default.
- W3112666175 hasConceptScore W3112666175C95444343 @default.
- W3112666175 hasIssue "Supplement_3" @default.
- W3112666175 hasLocation W31126661751 @default.
- W3112666175 hasLocation W31126661752 @default.
- W3112666175 hasOpenAccess W3112666175 @default.
- W3112666175 hasPrimaryLocation W31126661751 @default.
- W3112666175 hasRelatedWork W2110818089 @default.
- W3112666175 hasRelatedWork W2351796763 @default.
- W3112666175 hasRelatedWork W2351985199 @default.
- W3112666175 hasRelatedWork W2403502999 @default.
- W3112666175 hasRelatedWork W2567738959 @default.
- W3112666175 hasRelatedWork W2699314556 @default.
- W3112666175 hasRelatedWork W2923882796 @default.
- W3112666175 hasRelatedWork W2954318774 @default.
- W3112666175 hasRelatedWork W4297834875 @default.
- W3112666175 hasRelatedWork W4366141624 @default.
- W3112666175 hasVolume "22" @default.
- W3112666175 isParatext "false" @default.
- W3112666175 isRetracted "false" @default.
- W3112666175 magId "3112666175" @default.
- W3112666175 workType "article" @default.